These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23678583)

  • 1. [Epidemiology of schizophrenia].
    Nonaka S; Ichinose H; Kinoshita H; Nakane H
    Nihon Rinsho; 2013 Apr; 71(4):583-8. PubMed ID: 23678583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia: a concise overview of incidence, prevalence, and mortality.
    McGrath J; Saha S; Chant D; Welham J
    Epidemiol Rev; 2008; 30():67-76. PubMed ID: 18480098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Environmental risk factors for schizophrenia: a review].
    Vilain J; Galliot AM; Durand-Roger J; Leboyer M; Llorca PM; Schürhoff F; Szöke A
    Encephale; 2013 Feb; 39(1):19-28. PubMed ID: 23177330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drugs and risk of type 2 diabetes: an evidence-based approach.
    Bellantuono C; Tentoni L; Donda P
    Hum Psychopharmacol; 2004 Dec; 19(8):549-58. PubMed ID: 15378663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and safety of antipsychotic drugs during pregnancy.
    Einarson A; Boskovic R
    J Psychiatr Pract; 2009 May; 15(3):183-92. PubMed ID: 19461391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent development of understanding and psychiatric care on schizophrenia].
    Okazaki Y
    Nihon Rinsho; 2013 Apr; 71(4):577-82. PubMed ID: 23678582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, etiology, diagnosis, and treatment of schizophrenia.
    Ryan PM
    Am J Hosp Pharm; 1991 Jun; 48(6):1271-80. PubMed ID: 1677528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology.
    Tandon R; Keshavan MS; Nasrallah HA
    Schizophr Res; 2008 Jul; 102(1-3):1-18. PubMed ID: 18514488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
    Green AI
    J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS; Tripathi A
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the findings from the European SOHO study.
    Suarez D; Haro JM
    Expert Rev Neurother; 2008 Jun; 8(6):873-80. PubMed ID: 18505352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in schizophrenia.
    Abel KM; Drake R; Goldstein JM
    Int Rev Psychiatry; 2010; 22(5):417-28. PubMed ID: 21047156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.
    Hippisley-Cox J; Vinogradova Y; Coupland C; Parker C
    Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
    Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
    Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
    Taylor D; Hayhurst K; Kerwin R
    Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
    Novick D; Haro JM; Bertsch J; Haddad PM
    J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.
    Weiss EM; Bilder RM; Fleischhacker WW
    Psychopharmacology (Berl); 2002 Jun; 162(1):11-7. PubMed ID: 12107611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.